Literature DB >> 3411292

Induction of arthritis in monkeys by immunization with type II collagen.

T J Yoo1, S Y Kim, J M Stuart, R A Floyd, G A Olson, M A Cremer, A H Kang.   

Abstract

Immunization of two cynomolugus and three rhesus monkeys with purified type II collagen resulted in the development of polyarthritis. Arthritis first became clinically apparent 7 wk after primary immunization and persisted for 16 mo. Radiologic examination of the limbs demonstrated soft tissue swelling with severe joint destruction including loss of cartilage and bone. Involved joints eventually became ankylosed with permanent loss of some motion. All of the monkeys developed a response to the immunizing collagen as determined by ELISA of serum for antibodies. Arthritis was associated with weight loss and constitutional symptoms, including lethargy and refusal to eat. One monkey became so debilitated that it was necessary to euthanize it. Histologic examination of the joints showed synovial hypertrophy with pannus formation. A control monkey immunized with type I collagen suffered no apparent ill effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411292      PMCID: PMC2189004          DOI: 10.1084/jem.168.2.777

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen.

Authors:  E S Cathcart; K C Hayes; W A Gonnerman; A A Lazzari; C Franzblau
Journal:  Lab Invest       Date:  1986-01       Impact factor: 5.662

Review 2.  Collagen arthritis as a relevant model for rheumatoid arthritis.

Authors:  D E Trentham
Journal:  Arthritis Rheum       Date:  1982-08

3.  Morphologic demonstration of two stages in the development of type II collagen-induced arthritis.

Authors:  J P Caulfield; A Hein; R Dynesius-Trentham; D E Trentham
Journal:  Lab Invest       Date:  1982-03       Impact factor: 5.662

4.  The role of collagen autoimmunity in animal models and human diseases.

Authors:  J M Stuart; A S Townes; A H Kang
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

5.  Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats.

Authors:  T J Yoo; K Tomoda; J M Stuart; M A Cremer; A S Townes; A H Kang
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 May-Jun       Impact factor: 1.547

6.  Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice.

Authors:  J M Stuart; A S Townes; A H Kang
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

7.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

8.  Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule.

Authors:  K Terato; K A Hasty; M A Cremer; J M Stuart; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

  8 in total
  27 in total

Review 1.  Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

Review 4.  Rodent models of arthritis: relevance for human disease.

Authors:  R O Williams
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 5.  Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?

Authors:  R O Williams
Journal:  Springer Semin Immunopathol       Date:  1998

Review 6.  Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Authors:  K Yoshizaki; N Nishimoto; M Mihara; T Kishimoto
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis?

Authors:  N P Bakker; M G van Erck; C Zurcher; P Faaber; A Lemmens; M Hazenberg; R E Bontrop; M Jonker
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 8.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

9.  Acquired resistance to type II collagen-induced arthritis in rhesus monkeys is reflected by a T cell low-responsiveness to the antigen.

Authors:  N P Bakker; M G van Erck; L A 't Hart; M Jonker
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M J Rowley; I R Mackay; C A Brand; J F Bateman; D Chan
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.